Welcome to LookChem.com Sign In|Join Free

CAS

  • or

166271-34-7

Post Buying Request

166271-34-7 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

166271-34-7 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 166271-34-7 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,6,6,2,7 and 1 respectively; the second part has 2 digits, 3 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 166271-34:
(8*1)+(7*6)+(6*6)+(5*2)+(4*7)+(3*1)+(2*3)+(1*4)=137
137 % 10 = 7
So 166271-34-7 is a valid CAS Registry Number.

166271-34-7SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 20, 2017

Revision Date: Aug 20, 2017

1.Identification

1.1 GHS Product identifier

Product name N-(3-chloroquinoxalin-2-yl)-benzenesulfonamide

1.2 Other means of identification

Product number -
Other names N-(3-chloroquinoxalin-2-yl)benzenesulfonamide

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:166271-34-7 SDS

166271-34-7Relevant articles and documents

METHOD FOR PREPARING SUBSTITUTED N-(3-AMINO-QUINOXALIN-2-YL)-SULFONAMIDES AND THEIR INTERMEDIATES N-(3-CHLORO-QUINOXALIN-2-YL)SULFONAMIDES

-

Page/Page column 23, (2012/05/05)

The present invention provides a new synthesis for preparing N-(3-amino-quinoxalin-2-yl)-sulfonamides of general formulae (I) or (I') and intermediates sulfonamides of formula (II) or (II'):

METHODS OF USING PI3K AND MEK MODULATORS

-

Page/Page column 300, (2008/06/13)

The invention provides methods of treating cancer with a combination of compounds which inhibit kinases, more specifically MEK and PI3K.

PYRAZINE DERIVATIVES AND USE AS PI3K INHIBITORS

-

Page/Page column 51-52, (2008/06/13)

The present invention is related to pyrazine derivatives of Formula (I) in particular for the treatment and/or prophylaxis of autoimmune disorders and/or inflammatory diseases, cardiovascular diseases, neurodegenerative diseases, bacterial or viral infections, kidney diseases, platelet aggregation, cancer, transplantation, graft rejection or lung injuries.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 166271-34-7